LeonaBio (LONA) Total Liabilities (2019 - 2026)

LeonaBio (LONA) has 8 years of Total Liabilities data on file, last reported at $22.3 million in Q1 2026.

• Total Liabilities for Q1 2026 came in at $22.3 million, up 260.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.3 million (up 260.46% YoY), and the FY2025 annual result was $64.4 million, up 361.77% from the prior year.
• Total Liabilities declined to $22.3 million in Q1 2026 per LONA's latest filing, from $64.4 million in the prior quarter.
• Over five years, Total Liabilities peaked at $64.4 million in Q4 2025 and troughed at $3.2 million in Q3 2025.
• A 5-year average of $21.1 million and a median of $22.3 million in 2026 frame the typical range for Total Liabilities.
• On a YoY basis, Total Liabilities climbed as much as 361.77% in 2025 and fell as far as 88.67% in 2025.
• A 5-year view of Total Liabilities shows it stood at $23.0 million in 2022, then jumped by 30.59% to $30.1 million in 2023, then sank by 53.63% to $13.9 million in 2024, then jumped by 361.77% to $64.4 million in 2025, then tumbled by 65.37% to $22.3 million in 2026.
• Business Quant data shows LONA's Total Liabilities at $22.3 million in Q1 2026, $64.4 million in Q4 2025, and $3.2 million in Q3 2025.